72.33
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTVA Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$71.03
Aprire:
$72.04
Volume 24 ore:
4.63M
Relative Volume:
1.15
Capitalizzazione di mercato:
$49.12B
Reddito:
$17.18B
Utile/perdita netta:
$1.40B
Rapporto P/E:
35.28
EPS:
2.05
Flusso di cassa netto:
$2.59B
1 W Prestazione:
+1.63%
1M Prestazione:
-1.69%
6M Prestazione:
+15.07%
1 anno Prestazione:
+39.82%
Corteva Inc Stock (CTVA) Company Profile
Nome
Corteva Inc
Settore
Industria
Telefono
(833) 267-8382
Indirizzo
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Confronta CTVA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
CTVA
Corteva Inc
|
72.33 | 49.21B | 17.18B | 1.40B | 2.59B | 2.05 |
![]()
NTR
Nutrien Ltd
|
56.88 | 27.36B | 25.68B | 527.00M | 839.00M | 1.07 |
![]()
CF
Cf Industries Holdings Inc
|
86.42 | 13.38B | 6.13B | 1.34B | 1.86B | 7.59 |
![]()
MOS
Mosaic Company
|
32.21 | 10.31B | 11.06B | 367.80M | 212.50M | 1.16 |
![]()
ICL
Icl Group Ltd
|
6.09 | 7.77B | 6.84B | 407.00M | 755.00M | 0.32 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-03-31 | Aggiornamento | Argus | Hold → Buy |
2025-03-13 | Iniziato | Goldman | Buy |
2024-10-23 | Iniziato | Citigroup | Buy |
2024-10-16 | Aggiornamento | BofA Securities | Neutral → Buy |
2024-08-07 | Downgrade | Argus | Buy → Hold |
2024-04-12 | Downgrade | JP Morgan | Overweight → Neutral |
2024-03-01 | Iniziato | Wolfe Research | Outperform |
2024-02-12 | Aggiornamento | Loop Capital | Hold → Buy |
2024-02-02 | Aggiornamento | Exane BNP Paribas | Underperform → Neutral |
2023-11-27 | Downgrade | Berenberg | Buy → Hold |
2023-11-14 | Downgrade | Barclays | Overweight → Equal Weight |
2023-10-20 | Aggiornamento | Oppenheimer | Perform → Outperform |
2023-09-05 | Aggiornamento | UBS | Neutral → Buy |
2023-07-25 | Downgrade | Redburn | Buy → Neutral |
2023-06-28 | Iniziato | Canaccord Genuity | Buy |
2023-05-22 | Aggiornamento | Vertical Research | Hold → Buy |
2023-04-06 | Iniziato | Oppenheimer | Perform |
2023-01-19 | Iniziato | Wells Fargo | Overweight |
2023-01-11 | Aggiornamento | BofA Securities | Underperform → Neutral |
2022-11-16 | Downgrade | UBS | Buy → Neutral |
2022-11-15 | Downgrade | Loop Capital | Buy → Hold |
2022-08-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
2022-08-08 | Aggiornamento | ROTH Capital | Neutral → Buy |
2022-07-14 | Iniziato | Credit Suisse | Outperform |
2022-06-01 | Iniziato | Barclays | Overweight |
2022-05-06 | Downgrade | JP Morgan | Overweight → Neutral |
2022-04-14 | Aggiornamento | Loop Capital | Hold → Buy |
2022-04-14 | Downgrade | Vertical Research | Buy → Hold |
2022-01-31 | Aggiornamento | Redburn | Neutral → Buy |
2021-10-18 | Downgrade | Loop Capital | Buy → Hold |
2021-10-13 | Iniziato | Mizuho | Buy |
2021-10-08 | Iniziato | ROTH Capital | Buy |
2021-09-01 | Iniziato | Berenberg | Buy |
2021-08-09 | Aggiornamento | Monness Crespi & Hardt | Sell → Neutral |
2021-05-10 | Downgrade | BofA Securities | Buy → Underperform |
2021-04-19 | Aggiornamento | Loop Capital | Hold → Buy |
2021-02-05 | Aggiornamento | JP Morgan | Neutral → Overweight |
2021-02-05 | Reiterato | Monness Crespi & Hardt | Sell |
2020-12-18 | Downgrade | Susquehanna | Positive → Neutral |
2020-12-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2020-11-10 | Aggiornamento | Argus | Hold → Buy |
2020-10-19 | Aggiornamento | BofA Securities | Neutral → Buy |
2020-10-19 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
2020-08-11 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-08-10 | Downgrade | BofA Securities | Buy → Neutral |
2020-07-13 | Aggiornamento | BofA Securities | Underperform → Buy |
2020-06-26 | Iniziato | Cleveland Research | Neutral |
2020-06-16 | Aggiornamento | Vertical Research | Hold → Buy |
2020-06-08 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
2020-05-11 | Downgrade | BofA/Merrill | Neutral → Underperform |
2020-04-17 | Downgrade | BofA/Merrill | Buy → Neutral |
2020-04-17 | Aggiornamento | Loop Capital | Sell → Hold |
2020-04-01 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
2020-03-31 | Aggiornamento | Susquehanna | Neutral → Positive |
2020-03-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
2020-03-19 | Aggiornamento | Edward Jones | Hold → Buy |
2020-03-13 | Aggiornamento | BofA/Merrill | Neutral → Buy |
2020-03-10 | Aggiornamento | Monness Crespi & Hardt | Sell → Neutral |
Mostra tutto
Corteva Inc Borsa (CTVA) Ultime notizie
Corteva Shares Rise After Barclays Upgrade - MarketScreener
Corteva’s SWOT analysis: agricultural giant’s stock faces market headwinds - Investing.com
Barclays Upgrades Corteva to Overweight From Equalweight, Adjusts Price Target to $84 From $75 - MarketScreener
Barclays upgrades Corteva stock rating to Overweight on strong growth outlook - Investing.com Canada
Stock Analysis | Corteva OutlookMixed Signals Amid Analyst Optimism and Weak Technicals - AInvest
Agriculture Stocks Worth WatchingAugust 11th - MarketBeat
Wells Fargo Hikes Corteva (CTVA) Price Target Affirms ‘Overweight’ Rating - MSN
Corteva Earns Relative Strength Rating Upgrade; Hits Key Threshold - Investor's Business Daily
Corteva Shares Soar on Earnings Beat and Upgraded Guidance Despite 236th Trading Volume Ranking - AInvest
Best Agriculture Stocks To Follow NowAugust 10th - MarketBeat
Corteva beats estimates with rising demand for seed, crop protection; raises outlook - MSN
RBC Capital raises Corteva stock price target to $86 on Q2 beat - Investing.com Australia
Former Corteva leader tapped as next AgriNovus CEO - Inside INdiana Business
RBC Capital Adjusts Price Target on Corteva to $86 From $85, Maintains Outperform Rating - MarketScreener
Corteva (CTVA) Stock Surges 37.6% YOY on Strong Seed & Crop Protection GrowthNews and Statistics - IndexBox
Do Wall Street Analysts Like Corteva Stock? - Yahoo Finance
Investors Interested In Corteva, Inc.'s (NYSE:CTVA) Earnings - 富途牛牛
New Buy Rating for Corteva (CTVA), the Basic Materials Giant - The Globe and Mail
Corteva Gets Hold Rating from J.P. Morgan with $70 Price Target - AInvest
Corteva Reports Strong 2025 Earnings, Raises Guidance - The Globe and Mail
Top Agriculture Stocks To Keep An Eye OnAugust 7th - MarketBeat
RBC Raises Price Target on Corteva to $86 From $85, Keeps Outperform Rating - MarketScreener
Corteva, Inc. (NYSE:CTVA) Q2 2025 Earnings Call Transcript - Insider Monkey
JPMorgan Adjusts Price Target on Corteva to $70 From $65, Maintains Neutral Rating - MarketScreener
Citigroup Adjusts Price Target on Corteva to $83 From $85, Maintains Buy Rating - MarketScreener
Corteva stock price target raised to $85 from $84 at KeyBanc - Investing.com Nigeria
Deutsche Bank Adjusts Corteva Price Target to $83 From $85, Maintains Buy Rating - MarketScreener
Oppenheimer reiterates Outperform rating on Corteva stock after strong Q2 By Investing.com - Investing.com Nigeria
Oppenheimer reiterates Outperform rating on Corteva stock after strong Q2 - Investing.com
Corteva Inc (CTVA) Q2 2025 Earnings Call Highlights: Strong EBIT - GuruFocus
Research Alert: CFRA Upgrades Opinion On Shares Of Corteva, Inc. To Buy From Hold - 富途牛牛
Corteva Tolvera % JL Farmakis IncAd from 2025-08-08 - AgUpdate
Decoding Corteva Inc (CTVA): A Strategic SWOT Insight - GuruFocus
Corteva's 58.8% Trading Volume Surge Ranks 212th as Strong Q2 Earnings Drive Mixed Investor Sentiment - AInvest
Corteva (CTVA) Gets Boost from Oppenheimer Analyst Kristen Owen with New Buy Recommendation - AInvest
Corteva Earnings Call Highlights Robust Growth Amid Challenges - TipRanks
Corteva, Inc. (CTVA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Corteva, Inc. SEC 10-Q Report - TradingView
Earnings call transcript: Corteva Q2 2025 beats earnings, raises guidance By Investing.com - Investing.com Canada
Earnings call transcript: Corteva Q2 2025 beats earnings, raises guidance - Investing.com
Corteva raises 2025 operating EBITDA guidance to $3.8B amid record first-half performance and cost improvements - MSN
BNP Paribas Exane Adjusts Corteva Price Target to $70 From $65 - MarketScreener
UBS Maintains Buy Rating on CTVA, Raises Price Target | CTVA Sto - GuruFocus
Corteva's Q2 2025: Unpacking Contradictions in Crop Protection and Seed Pricing Strategies - AInvest
Corteva Raises 2025 Operating EBITDA Guidance to $3.8B Amid Record First-Half Performance and Cost Improvements. - AInvest
UBS Maintains Buy Rating on Corteva, Raises PT to $91 - AInvest
Transcript : Corteva, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Corteva Posts $3.35B Operating EBITDA in H1 2025, Eyes $3.85B for Full Year - global-agriculture.com
Corteva beats estimates with rising demand for seed, crop protection; raises outlook (CTVA:NYSE) - Seeking Alpha
The Chemours Company shares rise 3.42% premarket after Q2 2025 earnings call and Corteva's profit forecast raise. - AInvest
Corteva Reports Strong Q2 2025 Results - iGrow News
Corteva Inc Azioni (CTVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):